Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
apricoxib (1 trial)
balstilimab (2 trials)
cisplatin (platinol) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
daratumumab (darzalex) (1 trial)
durvalumab (imfinzi) (1 trial)
nivolumab (opdivo) (1 trial)
oncos-102 (5 trials)
pemetrexed (alimta) (1 trial)
qs-21 (1 trial)
tg01 vaccine (3 trials)
pembrolizumab (keytruda) (2 trials)
tg02 (1 trial)
Appendiceal Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 1)
Melanoma (Phase 1)
Mesothelioma (Phase 2)
Pancreatic Neoplasms (Phase 2)
Trials (10 total)
Trial APIs (13 total)